Medicare Picked 15 More High-Cost Drugs for Price Talks. What Changes in 2026, 2027, and 2028?
Medicare has three overlapping drug-price timelines. Here is what already changed in 2026, what starts in 2027, and why the newest 15 wait until 2028.
Local Health News and Alerts
-
-
Raw Cheddar Recall and E. coli Outbreak: What Families Need to Check and Why Raw Dairy Can Be Riskier
Raw Farm’s recalled raw cheddar is tied to an open E. coli investigation. Here’s which cheeses to check, symptoms to watch for, and why kids face higher risk.
-
How Much Exercise Adults Need for Health in 2026
Federal guidance still supports a simple goal: move more, sit less, and build in both aerobic activity and strength work each week.
-
FDA Authorized a Choking Suction Device. What Has—and Hasn’t—Changed for First Aid?
The FDA’s March 2026 update did not change first-aid basics: standard choking rescue still comes first, and one suction device is only a backup.
-
Athlete’s Foot That Won’t Clear? What the New CDC Ringworm Updates Mean for Your Feet
Most athlete’s foot improves with over-the-counter treatment, but the CDC says a rash that is not better after about two weeks should be checked.
-
OSHA just updated its workplace heat program. What outdoor and indoor workers should know before summer
OSHA updated its heat hazard program ahead of summer. Here’s what that means for inspections, who faces higher risk, and signs of heat illness.
-
Emergency Preparedness & Response | Infectious Diseases | Public Health Data & Surveillance | Vaccines
CDC’s New Measles Wastewater Map: What a Positive Signal Means for Families
CDC is now posting weekly measles wastewater detections. Here is what a positive signal can mean, what it cannot tell you, and what families should do now.
-
Adults 75 and Older Need Only One RSV Shot for Now: What New 2026 Guidance Means
Current U.S. guidance says adults 75 and older who have never had an RSV shot should get one dose now, with no repeat dose advised at this time.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Infectious Diseases | Maternal & Infant Health
Bicillin L-A Is Still in Short Supply: What the FDA’s Lentocilin Import Means for Syphilis Care
A federal import plan may ease some Bicillin L-A shortages, but access can still vary. For pregnancy, penicillin remains the only recommended syphilis treatment.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Neurological Disorders | Nutrition & Dietary Guidance
FDA warns Parkinson’s patients and caregivers about vitamin B6 deficiency and seizure risk with carbidopa/levodopa
The FDA now requires new warnings on carbidopa/levodopa labels about vitamin B6 deficiency and possible seizures, with advice on testing and monitoring.
-
Gum Disease Treatment Is Not One-and-Done: What Inflammation Means for Long-Term Tooth Support
Gum disease is chronic inflammation that can quietly weaken tooth support. Here is what bleeding, bone loss, and long-term maintenance really mean.
-
A New Study Suggests Medicare’s Insulin Cap Is Helping. Why Many Americans Still Pay More.
A new Medicare study suggests the $35 insulin cap is lowering patients’ costs. But supplies, other diabetes expenses, and gaps outside Medicare still matter.
-
FDA Cleared a New Once-Daily Psoriasis Pill. What That Means for People With Moderate to Severe Plaque Psoriasis
FDA approved Icotyde on March 17, 2026, giving some adults and teens with moderate to severe plaque psoriasis a new once-daily pill option.
-
Why a Proposed 2027 ACA Rule Could Keep Adult Dental Care Out of Marketplace Plans
A new CMS proposal could close a pathway for states to add adult dental benefits to ACA Marketplace plans in 2027, leaving many shoppers with separate coverage.
-
A New Alzheimer’s Blood Test Model May Predict When Symptoms Start — But It’s Not Ready for Routine Use
A new Alzheimer’s blood-test model may help researchers estimate when symptoms begin, but it is not ready for routine use or screening in healthy adults.
-
Cyber Security | Emergency Preparedness & Response | Hospitals & Healthcare Systems | Patient Safety & Quality
Why Health Care Cyberattacks Matter to Patients in 2026
Recent federal guidance and a cyber incident at medical-device maker Stryker are reminders that health care cyberattacks can affect access, privacy, and safety.
-
FDA Approved a New Daily Obesity Pill: What the Orforglipron Trials Found and What They Still Can’t Tell Us
The FDA approved daily obesity pill orforglipron on April 1. Here is what its main placebo-controlled trial found, and what patients still do not know.
-
What the New U.S. Dietary Guidelines Mean for Preventing Diabetes, Heart Disease, and Obesity
The 2025-2030 U.S. Dietary Guidelines put more weight on whole foods and less on added sugar and heavily processed foods. Here’s what changed.
-
New U.S. Cervical Cancer Screening Guidance Adds Self-Collection: What It Means for Women, Costs, and Follow-Up
A January 2026 federal update makes HPV-only screening the preferred option for many women 30 to 65 and adds self-collection as a choice.
-
Brain | Clinical Trials | Dementia | Elderly
A Short Brain-Training Program Was Linked to Fewer Dementia Diagnoses Over 20 Years. What Older Adults Should Know
An NIH-backed 20-year follow-up links one specific speed-training program—not all brain games—to fewer dementia diagnoses. Here’s what it means.
-
Who Should Be Screened for Osteoporosis? What the Latest U.S. Guidance Means for Adults at Fracture Risk
New U.S. guidance says women 65 and older should be screened for osteoporosis, and some younger postmenopausal women should be screened sooner.
-
New Blood Thinner Study May Change Conversations After a Dangerous Clot
A new trial found less clinically important bleeding with apixaban than rivaroxaban after a serious clot, but treatment changes still need a clinician.
End of content
End of content
